Cite
HARVARD Citation
Kim, S. et al. (n.d.). OP0002 No difference in the risk of malignancy in tocilizumab versus tnf inhibitor initiators in patients with rheumatoid arthritis: a multi-database cohort study. Annals of the rheumatic diseases. p. 50. [Online].